科研细胞

科研细胞



药靶细胞

药靶细胞



标准品

标准品



NGS靶向捕获探针

NGS靶向捕获探针



浏览量:

NFAT-Luc/Jurkat

所属分类

返回列表



零售价

0.0

元

市场价

0.0

元

浏览量:

产品编号

CBP74025

货号:

CBP74025

品牌:

Cobioer

规格:

T-25 Flask

物种:

组织:

数量

库存:

产品描述

参数

产品数据库

CBP74025
I. Background
The nuclear factor of activator T cells (NFAT) family of transcription factors plays an important role in immune response. T cell activation through the T cell synapse results in calcium influx. Increased intracellular calcium levels activate the calcium-sensitive phosphatase, calcineurin, which rapidly dephosphorylates the serine-rich region (SRR) and SP-repeats in the amino termini of NFAT proteins. This results in a conformational change that exposes a nuclear localization signal promoting NFAT nuclear import. In the nucleus, NFAT proteins cooperate with other proteins to bind to DNA.

II. Description
The NFAT Reporter – Jurkat Cell Line contains a firefly luciferase gene under the control of the NFAT response element stably integrated into Jurkat cells. The NFAT Reporter cell line has been validated for response to thapsigargin, ionomycin, and phorbol 12-myristate 13-acetate (PMA). It is useful as a control cell line for other NFAT reporter cell lines expressing various immune checkpoint receptors.

III. Introduction
Host Cell:	Jurkat
Expressed gene:	NFAT-Luciferase
Stability:	32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Synonym(s):	Nuclear factor of activated T cells; T cell
Freeze Medium:	90% FBS+10% DMSO
Culture Medium:	RPMI-1640+10%FBS+800ug/ml hygromycin
Mycoplasma Testing:	Negative
Storage:	Liquid nitrogen
Application(s):	Functional(Report Gene) Assay

IV. Description of Host Cell Line
Organism:	Homo sapiens, human
Tissue:	Peripheral blood
Disease:	Acute T cell leukemia
Morphology:	Lymphoblast
Growth Properties:	Suspension

Ⅴ. Representative Data

Figure 1. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. Jurkat/NFAT Luciferase Reporter cells were stimulated by Ionomycin, the S/B was 16.5-fold.